Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Google has expanded NotebookLM to allow sharing of notebooks, and more importantly, access to curated collections from ...

Artificial intelligence startup OpenEvidence banked a $210 million series B round as it looks to expand its strategic content ...

Traditionally, individuals asked health questions of their primary health care provider. Confidence in that provider as a ...

Most U.S. adults find the information to be at least somewhat reliable, new research shows. But experts say there is ...

OpenEvidence, dubbed the 'ChatGPT for doctors,' uses AI to simplify evidence-based medical information for physicians, now ...

Daniel Nadler started OpenEvidence to help physicians sort through a deluge of medical research. Now, he’s raised $210 ...

Large language models (LLMs) sometimes lose confidence when answering questions and abandon correct answers, according to a ...

What started as a casual beach activity has blossomed into a full-fledged hobby involving collecting, diving for and ...

Google last week announced a set of new open-source artificial intelligence (AI) tools aimed at supporting India’s ...

After teasing updates at I/O 2025, the company is now bringing some of them to life — starting with improvements to AI Mode, now powered by the newer Gemini 2.5 Pro model.

Google DeepMind subsidiary, Isomorphic Labs, has said it is ready to conduct human trials for drugs developed using its AlphaFold AI technology.